Arribas M, Cutler D F
MRC Laboratory for Molecular Cell Biology and Department of Biochemistry and Molecular Biology, University College London, Gower St, London WC1E 6BT, UK.
Traffic. 2000 Oct;1(10):783-93. doi: 10.1034/j.1600-0854.2000.011005.x.
Weibel-Palade bodies, the secretory granules of endothelial cells, possess two different membrane proteins. However, P-selectin is seen only in Weibel-Palade bodies in HUVECs, whereas CD63 is also seen in late endosomes/lysosomes. Since P-selectin is targeted to lysosomes in heterologous expression studies, we have determined whether a lysosomal targeting signal also operates within HUVECs. We have also examined the trafficking of CD63 to its two different intracellular locations. By following antibodies bound at the plasma membrane during stimulation, we have discovered that while half of the P-selectin recycles to the WPBs, 50% is rapidly delivered to a lamp-1-positive compartment. Thus, the lysosomal targeting signal of this protein also operates in HUVECs. CD63 is found constitutively at the cell surface of HUVECs and most of it is delivered to the late endosomes/lysosomes after internalisation. However, stimulation causes both a rise in the CD63 plasma membrane level and in the amount that recycles to the WPBs. Our data strongly suggest that the CD63 that originates in the WPB preferentially recycles to the granule rather than being delivered to the late endosome/lysosome, and that there are, therefore, two separate pools of this protein within HUVECs. Our findings indicate that although P-selectin and CD63 are both targeted to the same compartments from the PM, the kinetics and the ratio of their targeting to Weibel-Palade bodies versus lysosomes are very different.
魏尔-帕拉德小体是内皮细胞的分泌颗粒,含有两种不同的膜蛋白。然而,P-选择素仅在人脐静脉内皮细胞(HUVECs)的魏尔-帕拉德小体中可见,而CD63在晚期内体/溶酶体中也可见。由于在异源表达研究中P-选择素靶向溶酶体,我们确定了溶酶体靶向信号在HUVECs中是否也起作用。我们还研究了CD63向其两个不同细胞内位置的运输。通过追踪刺激过程中结合在质膜上的抗体,我们发现虽然一半的P-选择素循环回到魏尔-帕拉德小体,但50%迅速被转运到lamp-1阳性区室。因此,该蛋白的溶酶体靶向信号在HUVECs中也起作用。CD63在HUVECs的细胞表面组成性存在,内化后大部分被转运到晚期内体/溶酶体。然而,刺激会导致CD63质膜水平以及循环回到魏尔-帕拉德小体的量增加。我们的数据强烈表明,起源于魏尔-帕拉德小体的CD63优先循环回到颗粒而不是被转运到晚期内体/溶酶体,因此,在HUVECs中有两个独立的该蛋白池。我们的研究结果表明,尽管P-选择素和CD63都从质膜靶向相同的区室,但它们靶向魏尔-帕拉德小体与溶酶体的动力学和比例非常不同。